720 related articles for article (PubMed ID: 24435045)
1. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
2. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
4. Practical clinical use of dynamic susceptibility contrast magnetic resonance imaging for the surgical treatment of moyamoya disease.
Ishii Y; Nariai T; Tanaka Y; Mukawa M; Inaji M; Maehara T; Ohno K
Neurosurgery; 2014 Mar; 74(3):302-9. PubMed ID: 24335813
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
6. Contralateral progression and its risk factor in surgically treated unilateral adult moyamoya disease with a review of pertinent literature.
Lee SC; Jeon JS; Kim JE; Chung YS; Ahn JH; Cho WS; Son YJ; Bang JS; Kang HS; Oh CW
Acta Neurochir (Wien); 2014 Jan; 156(1):103-11. PubMed ID: 24201757
[TBL] [Abstract][Full Text] [Related]
7. Angiographic and Hemodynamic Features in Asymptomatic Hemispheres of Patients With Moyamoya Disease.
Sun H; Li W; Xia C; Ren Y; Ma L; Xiao A; You C; Liu Y; Tian R
Stroke; 2022 Jan; 53(1):210-217. PubMed ID: 34547926
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
9. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
10. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan.
Kuroda S; Hashimoto N; Yoshimoto T; Iwasaki Y;
Stroke; 2007 May; 38(5):1430-5. PubMed ID: 17395863
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
[TBL] [Abstract][Full Text] [Related]
12. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
Jiang H; Ni W; Xu B; Lei Y; Tian Y; Xu F; Gu Y; Mao Y
J Neurosurg; 2014 Nov; 121(5):1048-55. PubMed ID: 25127415
[TBL] [Abstract][Full Text] [Related]
13. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
14. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality.
Lee SB; Kim DS; Huh PW; Yoo DS; Lee TG; Cho KS
Acta Neurochir (Wien); 2012 Jul; 154(7):1179-87. PubMed ID: 22476796
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and disease progression in moyamoya disease patients with Graves disease.
Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
[TBL] [Abstract][Full Text] [Related]
17. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series.
Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G
World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589
[TBL] [Abstract][Full Text] [Related]
19. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
20. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
